Literature DB >> 6304132

Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.

O H Clark, P L Gerend, P Goretzki, R A Nissenson.   

Abstract

Experiments were performed to determine whether the TSH receptor-adenylate cyclase (AC) system in benign and malignant thyroid neoplasms differs from the TSH receptor-AC system in normal thyroid tissue removed from the same patients. TSH binding and AC assays were performed using the same in vitro conditions. TSH binding was rapid, reversible, saturable, and hormone specific in particulate fractions from both normal and neoplastic thyroid tissue. A positive correlation existed between the equilibrium constants for [125I]bovine ([125I]bTSH) TSH binding and the concentration of TSH required to activate AC, suggesting that binding sites were coupled to AC in neoplastic thyroid tissue. Mean values for dissociation constants (Kd1 and Kd2), capacity (site 2), as determined by Scatchard analysis, and nonspecific binding (NSB) for the TSH receptors were lower in neoplastic thyroid. Some normal thyroid tissue appeared to lack a high affinity site, and some tumors lacked a low affinity binding site. Hormone specificities (bTSH, human (h) TSH, hLH, hFSH, hGH, hACTH, and glucagon) in normal thyroid and neoplastic tissue were virtually identical. hFSH, hACTH, hGH, and glucagon failed to inhibit [125I]bTSH binding or stimulate AC in either normal or neoplastic thyroid tissue, whereas hLH inhibited [125I]bTSH binding and stimulated AC, but required 10- to 100-fold higher concentrations than hTSH or bTSH. The specific binding and NSB of [125I]bTSH in both normal and neoplastic thyroid tissue was highest at pH 7.0 and lowest at pH 8.3. In contrast to bTSH binding, TSH stimulation of AC was lowest at pH 7.0 in both normal and neoplastic tissues and highest at pH levels of 7.5-8.0. TSH binding and TSH stimulation of AC activity were highest in the absence of NaCl and decreased progressively as the salt concentration was increased in both normal and neoplastic thyroid tissues. Increasing the sucrose concentration and, thus, the osmolarity of the system had a minimal effect on the binding of [125I]bTSH. Preincubation with ammonium sulfate did not significantly influence binding. Basal AC activity and the AC response to TSH were greater in neoplastic thyroid than in normal tissues. These studies demonstrate that changes in salt concentration and pH affect the TSH receptor-cyclase system in a comparable fashion in normal and neoplastic thyroid tissues. The discriminatory properties of the TSH receptor are also maintained in thyroid neoplasms. Thyroid tumors, however, have a higher affinity for TSH and display a greater AC response to TSH than normal thyroid tissue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304132     DOI: 10.1210/jcem-57-1-140

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Effect of ethyl alcohol on the TSH-receptor-cyclase system in thyroid and nonthyroid tissues.

Authors:  O H Clark; P L Gerend
Journal:  World J Surg       Date:  1986-10       Impact factor: 3.352

Review 2.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

3.  Guanyl nucleotide regulatory proteins in neoplastic and normal human thyroid tissue.

Authors:  O H Clark; E T Gum; A E Siperstein; P L Gerend
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

4.  Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene.

Authors:  V N Gorelov; K Dumon; N S Barteneva; D Palm; H D Röher; P E Goretzki
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  Biological characteristics of adenomatous nodules, adenomas, and hyperfunctioning nodules as defined by adenylate cyclase activity and TSH receptors.

Authors:  C G Thomas; W Combest; R McQuade; H Jordan; R Reddick; S N Nayfeh
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

6.  Mechanisms for increased adenylate cyclase responsiveness to TSH in neoplastic human thyroid tissue.

Authors:  O H Clark; P L Gerend; R A Nissenson
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

7.  Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin?

Authors:  Kamile Gul; Didem Ozdemir; Ahmet Dirikoc; Ayten Oguz; Dilek Tuzun; Husniye Baser; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2010-03-13       Impact factor: 3.633

8.  Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications.

Authors:  P E Goretzki; J Lyons; S Stacy-Phipps; W Rosenau; M Demeure; O H Clark; F McCormick; H D Röher; H R Bourne
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

9.  Optimal Thyrotropin Suppression Therapy in Low-Risk Thyroid Cancer Patients after Lobectomy.

Authors:  Yu-Mi Lee; Min Ji Jeon; Won Woong Kim; Tae-Yon Sung; Ki-Wook Chung; Young Kee Shong; Suck Joon Hong
Journal:  J Clin Med       Date:  2019-08-22       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.